The activity is consistent with routine equity compensation management and tax settlement. Traders should monitor for any follow-up open-market selling beyond tax-related dispositions.
ZLAB drugs
ZLAB drug pipeline →Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Zai Lab CEO Du Ying exercised stock options and sold a small number of shares in the open market, while a significant number of shares were surrendered to cover tax obligations related to equity awards. The majority of transactions were non-cash events tied to equity compensation.
Key Financial Metrics
Key Facts
- CEO Du Ying exercised derivatives for 524,839 shares (two tranches of 261,092 and one of 2,655) with a total intrinsic value of $454,300.08.
- 32,419 and 353,430 shares were granted to Du Ying at $0, representing non-cash equity awards.
- Du Ying sold 1,067 shares in the open market for $20,363, a minimal amount relative to holdings.
- 116,936 shares were surrendered to cover taxes (code F) valued at $2.27M, a common practice during equity vesting.
- All transactions occurred within a 7-day window, forming an insider trading cluster.
Financial Impact
$2.73M in total economic activity, primarily from tax withholding and option exercises; only $20.4K in open-market selling.
Risk Factors
- Perception of insider selling, though most was non-cash tax withholding.
- Potential dilution from newly issued shares underlying exercised options and awards.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (7 trades, 7d window) | cluster-ZLAB-1773691614879 |
Track record
23 reports on ZLAB
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +13.13% at T+20 after the May 7, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
- Nov 5, 202611d ago 8-K Neutral 5/10 Entry $22.60 to $25.48 Now $23.47 +3.85% ▲ +12.74% +12.43% vs SPY
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $24.03 to $24.34 Now $23.47 −2.33% ▲ +1.29% +0.58% vs SPY
- Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $25.64 to $26.17 Now $23.47 −8.46% ▲ +2.07% +1.75% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 2/10 Entry $25.90 to $25.64 Now $23.47 −9.38% ▼ −1.00% −0.53% vs SPY
- Aug 12, 202613w ago 144 Neutral 2/10 Entry $25.49 to $26.03 Now $23.47 −7.92% ▲ +2.12% +1.42% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $19.12 to $19.08 Now $23.47 +22.75% ▼ −0.21% −1.08% vs SPY
- Jun 29, 202620w ago Insider Cluster Neutral 3/10 Entry $19.00 to $19.15 Now $23.47 +23.53% ▲ +0.79% +0.92% vs SPY
- Jun 11, 202622w ago Institutional Cluster Bearish 5/10 Entry $17.64 to $17.07 Now $23.47 −33.05% ▲ +3.23% +3.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers